Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GENE | AMGN | GILD | CELG | VRTX |
| Company | Genetic Tech Spn ADR | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.8400 | 337.03 | 84.39 | 108.01 | 477.70 |
| High | 0.8400 | 338.28 | 84.65 | 108.59 | 479.01 |
| Low | 0.8380 | 334.61 | 83.93 | 107.27 | 476.50 |
| Last | 0.8268 | 337.38 | 83.62 | 108.24 | 478.14 |
| Change | +0.0308 | +4.46 | -0.27 | +0.11 | +3.98 |
| % Change | +3.87% | +1.34% | -0.32% | +0.10% | +0.84% |
| Volume | 3,231 | 201,081 | 797,251 | 191,230,496 | 78,711 |
| 20-Day Average Volume | 13,002 | 1,685,095 | 6,278,814 | 16,188,930 | 941,341 |
| Previous Close | 0.7960 | 332.92 | 83.89 | 108.13 | 474.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8693 | 329.60 | 80.07 | 108.17 | 479.92 |
| 20-Day Raw Stochastic | 33.33% | 85.90% | 90.04% | 63.25% | 46.27% |
| 20-Day Relative Strength | 43.08% | 57.84% | 71.95% | 64.69% | 49.93% |
| Weighted Alpha | -64.19 | +27.21 | +18.32 | +46.30 | +33.96 |
| Today's Opinion | 88% Sell | 96% Buy | 88% Buy | 100% Buy | 40% Buy |
| Previous Opinion | 88% Sell | 88% Buy | 88% Buy | 100% Buy | 40% Buy |
| Last Month's Opinion | 88% Sell | 88% Buy | 56% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.25% since 09/12/24 | +1.85% since 09/12/24 | +0.94% since 09/12/24 | -1.97% since 11/13/19 | +0.07% since 09/12/24 |
| Low | 0.7900 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 107.27 on 11/20/19 | 473.75 on 09/18/24 |
| High | 0.8400 on 09/19/24 | 339.00 on 09/18/24 | 84.64 on 09/19/24 | 110.53 on 11/14/19 | 490.15 on 09/16/24 |
| 1-Month | |||||
| %Chg | +3.70% since 08/19/24 | +2.50% since 08/19/24 | +12.75% since 08/19/24 | +5.14% since 10/18/19 | -1.86% since 08/19/24 |
| Low | 0.7900 on 09/13/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 102.40 on 10/21/19 | 460.69 on 09/11/24 |
| High | 0.9400 on 08/26/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 500.25 on 08/30/24 |
| 3-Month | |||||
| %Chg | -51.16% since 06/18/24 | +9.87% since 06/18/24 | +32.92% since 06/18/24 | +13.63% since 08/20/19 | +2.51% since 06/18/24 |
| Low | 0.6930 on 08/15/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 93.41 on 08/23/19 | 458.04 on 08/13/24 |
| High | 1.7500 on 06/24/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 510.64 on 08/01/24 |
| 6-Month | |||||
| %Chg | -68.89% since 03/19/24 | +23.72% since 03/19/24 | +14.34% since 03/19/24 | +14.14% since 05/20/19 | +15.36% since 03/19/24 |
| Low | 0.6930 on 08/15/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 89.08 on 07/23/19 | 391.01 on 04/18/24 |
| High | 3.5900 on 04/12/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 510.64 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,508 | 178,589,936 | 104,514,608 | 77,035,920 | 122,358,416 |
| Shares Outstanding, K | 4,407 | 536,435 | 1,245,853 | 711,714 | 258,053 |
| Annual Sales | 5,850,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -7,910,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 3,330,985 | 8,388,000,000 | 6,954,000,000 | 4,520,000,000 | 2,645,600,000 |
| Last Quarter Net Income | -2,501,777 | 746,000,000 | 1,614,000,000 | 1,691,000,000 | -3,593,600,000 |
| 60-Month Beta | 1.12 | 0.61 | 0.18 | 1.41 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 2.99 on 10/31/19 | -12.83 on 08/01/24 |
| Latest Earnings Date | 09/18/24 | 10/29/24 | 11/05/24 | 10/31/19 | 11/04/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.89 | 17.67 | 10.99 | 0.00 |